Le­fkof­sky’s Tem­pus raises $70 mil­lion

Modern Healthcare - - REGIONAL NEWS -

Chicago-based Tem­pus, Eric Le­fkof­sky’s can­cer-data com­pany, has got­ten a $70 mil­lion boost from New En­ter­prise As­so­ci­ates and Rev­o­lu­tion Growth, two Wash­ing­ton, D.C., venture cap­i­tal funds. To­tal in­vest­ments in Tem­pus have grown to $130 mil­lion. The lat­est round val­ues the com­pany at about $700 mil­lion.

Tem­pus was launched two years ago by Le­fkof­sky, who co-founded and was CEO of Groupon, af­ter his wife was treated for breast can­cer. In the past year, Tem­pus has signed up re­search cen­ters and hos­pi­tals like North­west­ern Univer­sity’s Lurie Can­cer Cen­ter and Cleve­land Clinic as part­ners.

Hos­pi­tals send pa­tients to Tem­pus for ge­netic se­quenc­ing and anal­y­sis, and pro­vide non-iden­ti­fi­able data to Tem­pus. The com­pany’s soft­ware plat­form uses the data to in­form doc­tors on treat­ment op­tions, show­ing how other pa­tients with sim­i­lar ge­netic pro­files have re­sponded to par­tic­u­lar ther­a­pies.

One of the big chal­lenges was gath­er­ing enough part­ners to build a crit­i­cal mass of data. Le­fkof­sky said the ad­di­tional funds will help Tem­pus build out that data­base. —John Pletz, Crain’s Chicago Busi­ness

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.